AIDS Drug Assistance Program (ADAP) Data Report

The RWHAP ADAP is a state and territory-administered program that provides Food and Drug Administration (FDA)-approved medications to low-income people with HIV who have limited or no health coverage from private insurance, Medicaid, or Medicare. RWHAP ADAP funds may also be used to purchase health insurance for eligible clients and for services that enhance access, adherence, and monitoring of drug treatments. The HRSA HAB uses the ADR to evaluate the national impact of the RWHAP ADAP, by providing client-level data on individuals being served, services being delivered, and costs associated with these services.

The latest form for AIDS Drug Assistance Program (ADAP) Data Report expires 2023-06-30 and can be found here.